Shingrix Guidelines Posted in MMWR
Read more here
Author: Kate Smith
NFID News: 9 Important Things To Know About Shingles Vaccination
new vaccine to prevent shingles (Shingrix®) was licensed for adults age 50 years and older by the US Food and Drug Administration (FDA), and in October 2017, it was recommended for healthy adults age 50 years and older as well as adults who previously received the current shingles vaccine (Zostavax®) by the Advisory Committee on Immunization Practices (ACIP). Read more.
H3N2 Component of 2017 Flu Vaccine Only 10% Effective?!
Interesting article from the New England Journal of Medicine about the effectiveness of Australia’s 2017 flu vaccine, and what doctors are seeing in the United States so far. The investigators determined that circulating influenza A (H3N2) viruses possessed an HA glycosylation site that was lost in the vaccine strain during egg adaptation, and both ferret and human antibodies elicited by that vaccine strain poorly neutralized circulating virus. The researchers also compared antibody responses elicited by vaccine antigens prepared using eggs, cell culture, and the recombinant DNA baculovirus system. They found that most people who mounted a strong antibody response to Read More …
Preventing Shoulder Injuries after Vaccination
The CDC has distributed this refresher on intramuscular injection of vaccines. SIRVA (Shoulder Injuries Related to Vaccine Administration) has been on the rise, and all providers should remind themselves how and where to give an IM Vaccine. Find the refresher here.
New From The IAC:
Vaccinating Adults: A Step-by-Step Guide
WASHINGTON – In an unusually close vote, the Advisory Committee on Immunization Practices recommended the use of Shingrix (GSK) for adults ages 50 and older as a vaccine to prevent Shingles. Read More
CDC Press Release: New study shows Tdap vaccination during pregnancy can prevent whooping cough in babies
Press Release For Immediate Release Thursday, September 28, 2017 Contact: CDC Media Relations (404) 639-3286 New study shows Tdap vaccination during pregnancy can prevent whooping cough in babies Less than half of pregnant women in the United States take advantage of vaccination A new CDC study published today in Clinical Infectious Diseases reported that vaccination with whooping cough vaccine, Tdap, during the third trimester of pregnancy prevented more than three out of four (78 percent) cases of whooping cough (also known as pertussis) in babies younger than two months. However, only 49 percent of pregnant women who delivered between Read More …
WEBINAR: Aging & the Immune System: Rethinking Vaccines for Older Adults
Tuesday, September 26, 2017 12:00 – 1:00 pm ET The immune system changes with age, which can leave older adults more vulnerable to infectious diseases like flu, pneumonia, and shingles. Join experts to learn more about the changing immune system and how new research is changing the design of vaccines for older adults. Free continuing education available. Register HERE.
WHO Vaccination and Trust Library of Sources
The WHO Europe has prepared a Vaccination and Trust Library. This website lists many different helpful links like: Questions journalists always ask in a crisis Four steps that may erode trust Tips for spokespersons Crisis communications plan template Checklist for preparedness Checklist for communication and advocacy when introducing a new vaccine
PEDIATRICS: Adverse Vax Events Unlikely to Recur in Kids
Read the article on MedpageToday! Adverse events to vaccinations were unlikely to recur in pediatric patients when they were immunized again, a systematic literature review found. Risk of recurrence for serious adverse events following immunization, such as anaphylaxis, seizures, or apnea in term infants, was lower than 1%, reported Joseline Guetsop Zafack, MD, of Laval University in Quebec, and colleagues.